Company intelligence / Profile preview
HoneyBear Biosciences, Inc
Taipei, N/A, Taiwanhoneybearbio.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
HoneyBear Biosciences is a Taiwan-based biotech company founded in 2021. It specializes in next-generation antibody-drug conjugate technologies using its proprietary CoNectar™ platform for precise and dual payload attachment. The company has received industry recognition for innovation in ADCs, including the “Best ADC Developer in Taiwan” award at the 2025 Asia-Pacific Biopharma Excellence Awards. Recent partnerships include licensing deals with Singapore’s A*STAR to accelerate development of Antibody Radionuclide Conjugates for cancer therapy. Clinical results are not yet available; programs are preclinical or entering early clinical stages[3][4][5].
- Therapeutic areas
- Oncology
- Modalities
- Antibody-drug conjugates (ADCs)Antibody radionuclide conjugates (ARCs)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Agency for Science, Technology and Research (A*STAR), Singapore – exclusive antibody license and multi-cistronic expression vector technology for ARC program[5].Multiple co-development/licensing partnerships with global biotech/pharma companies targeted as part of business strategy[1][7].
Beyond the preview
Go deeper on HoneyBear Biosciences, Inc.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HoneyBear Biosciences, Inc.